Midori’s innovative process creates novel oligosaccharides that interact with innate microbes to support gut health in animals.
Our deep understanding of carbohydrate science allows us to control oligosaccharide structure and provide creative solutions that drive value in the animal production sector.
Unlike pre-biotics and other comparable products, Midori’s oligosaccharides are produced to tight specifications and high purity. Our oligosaccharides offer a significant benefit at low inclusion rate.
Midori is developing innovative health solutions for the monogastric, ruminant, and aquaculture sectors, such as GlycoDex™, a replacement for antibiotics in poultry production.